DK1029548T3 - Fremgangsmåde til opretholdelse af kvaliteten af vandige, parenterale oplösninger af thrombomodulin under lagring og transport - Google Patents

Fremgangsmåde til opretholdelse af kvaliteten af vandige, parenterale oplösninger af thrombomodulin under lagring og transport

Info

Publication number
DK1029548T3
DK1029548T3 DK98947842T DK98947842T DK1029548T3 DK 1029548 T3 DK1029548 T3 DK 1029548T3 DK 98947842 T DK98947842 T DK 98947842T DK 98947842 T DK98947842 T DK 98947842T DK 1029548 T3 DK1029548 T3 DK 1029548T3
Authority
DK
Denmark
Prior art keywords
thrombomodulin
aqueous
solution
quality
aqueous parenteral
Prior art date
Application number
DK98947842T
Other languages
English (en)
Inventor
Masaki Yui
Akira Yokozawa
Tomoyo Murata
Kazuhisa Tsuruta
Hirotomo Shimizu
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26554271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1029548(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Application granted granted Critical
Publication of DK1029548T3 publication Critical patent/DK1029548T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK98947842T 1997-10-15 1998-10-13 Fremgangsmåde til opretholdelse af kvaliteten af vandige, parenterale oplösninger af thrombomodulin under lagring og transport DK1029548T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28165997 1997-10-15
JP30852397 1997-11-11
PCT/JP1998/004609 WO1999018994A1 (fr) 1997-10-15 1998-10-13 Procede pour conserver la qualite d'une solution parenterale aqueuse de thrombomoduline pour l'entreposage ou la distribution

Publications (1)

Publication Number Publication Date
DK1029548T3 true DK1029548T3 (da) 2007-07-02

Family

ID=26554271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98947842T DK1029548T3 (da) 1997-10-15 1998-10-13 Fremgangsmåde til opretholdelse af kvaliteten af vandige, parenterale oplösninger af thrombomodulin under lagring og transport

Country Status (14)

Country Link
US (1) US6808706B1 (da)
EP (1) EP1029548B1 (da)
JP (1) JP4460762B2 (da)
KR (1) KR100373480B1 (da)
CN (1) CN1275916A (da)
AT (1) ATE358496T1 (da)
AU (1) AU729876B2 (da)
CA (1) CA2306206A1 (da)
DE (1) DE69837493T2 (da)
DK (1) DK1029548T3 (da)
ES (1) ES2281137T3 (da)
HK (1) HK1027514A1 (da)
PT (1) PT1029548E (da)
WO (1) WO1999018994A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006346494A (ja) * 1999-02-22 2006-12-28 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
US6585971B1 (en) * 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
DE60034366T2 (de) * 1999-12-22 2007-12-20 Glaxo Group Ltd., Greenford Verfahren zur herstellung pharmazeutischer formulierungen
IL150736A0 (en) * 2000-03-14 2003-02-12 Mayr Anton Altered strain of the modified vaccinia virus ankara (mva)
WO2003061687A1 (en) * 2002-01-18 2003-07-31 Asahi Kasei Pharma Corporation High-concentration preparation of soluble thrombomodulin
AU2007240732B2 (en) * 2006-04-21 2013-07-04 Amgen, Inc. Buffering agents for biopharmaceutical formulations
AU2008230465B2 (en) 2007-03-23 2011-10-13 Asahi Kasei Pharma Corporation Method for producing high-purity soluble thrombomodulin
AU2009210741A1 (en) * 2008-02-07 2009-08-13 Amgen Inc. Stabilized protein compositions
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および／または治療剤
KR101879885B1 (ko) 2010-09-17 2018-07-18 박스알타 인코퍼레이티드 약산성 내지 중성 ｐｈ에서 히스티딘을 갖는 수성 제형을 통한 면역글로불린의 안정화
CN110496099B (zh) * 2013-09-11 2022-06-21 伊戈尔生物药品股份有限公司 包含粘度降低剂的液体蛋白质制剂
MX2017004306A (es) 2014-10-01 2017-12-20 Eagle Biologics Inc Formulaciones de polisacáridos y ácido nucleico que contienen agentes de reducción de viscosidad.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2738428B2 (ja) * 1987-01-08 1998-04-08 旭化成工業株式会社 トロンビンによるプロテインｃの活性化を促進する作用を有するペプチド
DE3856335T2 (de) 1987-01-08 2000-01-27 Asahi Chemical Ind Peptid zur beschleunigung der wirkung des proteins-c mit thrombin
US4912207A (en) 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
JPH02255699A (ja) 1989-03-28 1990-10-16 Asahi Chem Ind Co Ltd 新規血液抗凝固物質及びその製法
JPH05213998A (ja) 1990-08-03 1993-08-24 Asahi Chem Ind Co Ltd 新規なポリペプチド及びこれを有効成分とする 医薬組成物
JPH05310787A (ja) * 1992-05-01 1993-11-22 Asahi Chem Ind Co Ltd 新規なポリペプチド
JP3007785B2 (ja) 1993-03-16 2000-02-07 旭化成工業株式会社 トロンボモジュリン組成物およびその変性防止方法
DE59402391D1 (de) * 1993-12-13 1997-05-15 Peter Lisec Vorrichtung zum teilen von verbundglas
AU692497B2 (en) 1993-12-17 1998-06-11 Asahi Kasei Pharma Corporation Soluble thrombomodulin-containing pharmaceutical composition

Also Published As

Publication number Publication date
EP1029548A1 (en) 2000-08-23
KR100373480B1 (ko) 2003-02-25
ATE358496T1 (de) 2007-04-15
PT1029548E (pt) 2007-05-31
AU729876B2 (en) 2001-02-15
US6808706B1 (en) 2004-10-26
CA2306206A1 (en) 1999-04-22
JP4460762B2 (ja) 2010-05-12
DE69837493T2 (de) 2007-12-13
ES2281137T3 (es) 2007-09-16
DE69837493D1 (de) 2007-05-16
KR20010031153A (ko) 2001-04-16
EP1029548A4 (en) 2004-07-14
WO1999018994A1 (fr) 1999-04-22
EP1029548B1 (en) 2007-04-04
AU9460398A (en) 1999-05-03
HK1027514A1 (en) 2001-01-19
CN1275916A (zh) 2000-12-06

Similar Documents

Publication Publication Date Title
DK1029548T3 (da) Fremgangsmåde til opretholdelse af kvaliteten af vandige, parenterale oplösninger af thrombomodulin under lagring og transport
DE69412120D1 (de) Implantat-aufbau
DE69107932D1 (de) Stabile wässerige Zubereitung.
ZA92297B (en) Dispenser adapted for combined continuous and instant operation
NZ232055A (en) Aqueous liquid detergents containing organic surface active agents, peroxy-bleach compound, enzyme and aliphatic carboxylic acid as enzyme stabiliser
KR910020476A (ko) 액정패널의 제조방법 및 장치
CA2258041A1 (en) Solvent resupply method for use with a carbon dioxide cleaning system
DK0518720T3 (da) Ikke-vandigt flydende maskinopvaskemiddel indeholdende enzymer
ATE209437T1 (de) Granuläre formulierung von nematoden mit hoher lagerstabilität
IT8748705A0 (it) Composizione liquida acquosa per lavastoviglie,contenente enzimi stabilizzati
JPS5581813A (en) Composition containing coenzyme q10 and its perparation
MXPA00002505A (es) Solucion de lisina acuosa estable.
ES2070120T3 (es) Articulo higienico de celulosa.
IL105533A0 (en) Stable injectable polypeptide compositions
DE68922258D1 (de) Flüssige Waschmittel.
JPS63248679A (ja) 生花包装体
EP0351782A3 (en) Optically active compounds liquid crystal composition containing said compound, and liquid crystal optical modulator using said composition
JPS6443173A (en) Tasteful drink sealed in container
SE8803481D0 (sv) Low viscosity stable non-aqueous suspension containing organophilic clay and low density filler
JPS544088A (en) Manufacture for semiconductor laser
DE69900935D1 (de) Brühsystem
WO1988003378A3 (en) Cut flower storage and display unit and system
JPH0189966U (da)
UA5668A1 (uk) Спосіб стабілізації рідких комплексних добрив
JPS57198622A (en) Liquid phase epitaxial growth